Cyanotech Corporation

CYAN

US2324373016

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 10:38:49 2024-04-26 am EDT			5-day change	1st Jan Change
0.2999 ^USD	-0.20%		-14.44%	-66.30%

Feb. 22	Cyanotech Corporation(NasdaqCM:CYAN) dropped from S&P TMI Index	CI
Feb. 19	Cyanotech Corporation(NasdaqCM:CYAN) dropped from NASDAQ Composite Index	CI

Cyanotech Corporation Reports Earnings Results for the Full Year Ended March 31, 2023

June 27, 2023 at 04:06 pm EDT

Cyanotech Corporation reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was USD 23.18 million compared to USD 35.97 million a year ago. Net loss was USD 3.44 million compared to net income of USD 2.15 million a year ago.

Basic loss per share from continuing operations was USD 0.55 compared to basic earnings per share from continuing operations of USD 0.35 a year ago. Diluted loss per share from continuing operations was USD 0.55 compared to diluted earnings per share from continuing operations of USD 0.35 a year ago.

Latest news about Cyanotech Corporation

Cyanotech Corporation(NasdaqCM:CYAN) dropped from S&P TMI Index	Feb. 21	CI
Cyanotech Corporation(NasdaqCM:CYAN) dropped from NASDAQ Composite Index	Feb. 18	CI
Transcript : Cyanotech Corporation, Q3 2024 Earnings Call, Feb 09, 2024	Feb. 09
Earnings Flash (CYAN) CYANOTECH CORPORATION Posts Q3 Revenue $5.6M	Feb. 08	MT
Cyanotech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 08	CI
Cyanotech Insider Bought Shares Worth $400,000, According to a Recent SEC Filing	Dec. 19	MT
Cyanotech Corporation announced that it has received $0.4 million in funding from The Michael Arlen Davis Revocable Trust	Dec. 14	CI
Cyanotech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 08	CI
Cyanotech Corporation Enters into A Second Amendment to the Amended and Restated Promissory Note with Skywords Family Foundation, Inc	23-08-17	CI
Transcript : Cyanotech Corporation, Q1 2024 Earnings Call, Aug 14, 2023	23-08-14
Earnings Flash (CYAN) CYANOTECH CORPORATION Posts Q1 Revenue $5.1M	23-08-11	MT
Cyanotech Corporation Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Cyanotech Corporation Appoints Collette Kakuk as Chief Strategic and Commercial Officer	23-08-01	CI
Cyanotech Corporation and Skywords Family Foundation, Inc. Executes Letter of Intent to Commence Drafting and Negotiating A Definitive Second Amendment to the Amended and Restated Promissory Note	23-07-05	CI
Earnings Flash (CYAN) CYANOTECH CORPORATION Reports Q4 Revenue $5.4M	23-06-27	MT
Cyanotech Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-27	CI
Cyanotech Corporation Auditor Raises 'Going Concern' Doubt	23-06-26	CI
Earnings Flash (CYAN) CYANOTECH CORPORATION Reports Q3 Revenue $5.9M	23-02-09	MT
Cyanotech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-09	CI
Top Premarket Decliners	23-01-17	MT
Cyanotech Corporation Enters into First Amendment to Amended and Restated Promissory Note with Skywords Family Foundation, Inc	22-12-19	CI
Cyanotech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-09	CI
Earnings Flash (CYAN) CYANOTECH CORPORATION Posts Q1 Revenue $6.7M	22-08-10	MT
Cyanotech Corporation Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-10	CI
Transcript : Cyanotech Corporation, 2022 Earnings Call, Jun 23, 2022	22-06-23

Chart Cyanotech Corporation

Duration

Period

More charts

Company Profile

Cyanotech Corporation is an agricultural company. It is engaged in the production of natural products derived from microalgae grown in complex and intricate agricultural systems on the Kona coast of Hawaii. It cultivates, on a large-scale basis, two microalgal species from which its two major product lines, natural astaxanthin products and spirulina products, are derived. Its products include BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica. BioAstin Hawaiian Astaxanthin is a dietary antioxidant shown to support and maintain the bodyâs natural inflammatory response, to enhance skin, and to support eye, joint and immune health. BioAstin Hawaiian Astaxanthin has expanding applications as a human dietary supplement and dietary ingredient. Hawaiian Spirulina Pacifica is a nutrient-rich dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids. Its products are sold as consumer-packaged goods.

Sector

Pharmaceuticals

Calendar

2024-06-24 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CYANOTECH CORPORATION	-66.30%	2.08M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B